About this document "AR-V7 circulating tumor cell test": What is the accuracy rate of AR-V7 circulating tumor cell test

I notice that the document provided does not contain any specific information about the accuracy rate of the AR-V7 circulating tumor cell test.

However, I can provide some context from authoritative sources about this test:

According to NCCN Guidelines for Prostate Cancer (current version):

• AR-V7 testing is considered investigational, which is consistent with the document's listing of its guideline source as "investigational"
• The test is not yet included in standard treatment algorithms

According to ASCO Guidelines:

• While AR-V7 testing shows promise for predicting treatment resistance, there is not yet sufficient evidence to recommend routine clinical use
• More validation studies are needed to establish definitive accuracy rates

For specific accuracy information, I recommend:

1. Consulting with your oncologist who can share the latest clinical data
2. Discussing whether this test would be appropriate in your specific case, especially given its cost ($1000) and lack of insurance coverage as noted in the document

Remember that this test is specifically for patients with castration-resistant prostate cancer, as indicated in the "Requirements" section of the document.